Cansino Biologics Inc.
Clinical trials sponsored by Cansino Biologics Inc., explained in plain language.
-
One shot, six shields: new vaccine trial for kids aims to simplify protection
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new combination vaccine designed to protect children against six serious diseases: whooping cough, tetanus, diphtheria, Hib, and multiple types of meningococcal meningitis. The main goals are to check if the vaccine is safe and if it triggers a good immune…
Phase: PHASE1 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:41 UTC
-
New shot for babies aims to beat dangerous pneumonia
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine designed to protect infants from serious bacterial infections like pneumonia and meningitis. About 600 healthy babies in Thailand, starting at 6 weeks old, will receive either the new vaccine or an existing one to compare how well they work and…
Phase: PHASE3 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test Next-Generation shot in fight against TB
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing a new experimental vaccine designed to protect against tuberculosis (TB). It will involve 36 healthy adults aged 18-49 to check if the vaccine is safe and if it triggers a protective immune response. Participants will receive either one of two do…
Phase: PHASE1 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 18, 2026 14:41 UTC